Jessica Longo Discusses the Changing Patient Access Landscape

A panel examines the gross-to-net bubble across various product mixes, how pricing impacts market access, and more.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

A session investigates the drivers of these shortages and ways to mitigate them.

Breakout session explores how direct-to-patient models shorten the time to diagnosis and therapy to improve patient outcomes.

The seminar focuses on US supply chain resiliency, while remaining compliant and preserving patient access.

A case study explores a way to potentially transform commercial organizations, while driving revenue growth.